Creatine for Menopause: What the Evidence Actually Shows

Creatine is a fuel-recycling molecule, not a hormone and not a stimulant.

Your muscles store creatine as phosphocreatine, which acts as a rapid battery for regenerating ATP - the molecule your cells spend when they contract, think, or do almost anything. During short, hard efforts like standing up from a low chair, climbing stairs with shopping, or the last two reps of a set, phosphocreatine is what lets the muscle keep firing before slower energy systems catch up.

You already make about 1 gram a day in your liver, kidneys and pancreas, and you get another gram or so from meat and fish. Supplementing raises the amount stored in muscle by roughly 20-40% in people who start with lower stores. Women tend to have lower baseline muscle creatine stores than men - partly diet, partly body composition - which is one reason researchers think women may respond well.

Here's why this matters specifically in midlife. After menopause, falling estrogen accelerates the loss of muscle mass and strength. Estrogen has direct effects on muscle satellite cells (the repair cells) and on inflammation, and its withdrawal tilts the balance toward breakdown. Women can lose meaningful muscle in the years around the final period, which affects metabolism, balance, blood sugar handling and independence later on. That's the condition called sarcopenia, and it's the main reason creatine gets discussed in menopause at all.

Creatine is not a menopause treatment. It doesn't touch hot flashes, doesn't replace hormones, and won't fix sleep. What it may do is make the strength training you're already doing slightly more productive - which, given how much strength training matters after 45, is not nothing.

Yes - modestly, and only when paired with resistance training.

The cleanest summary comes from a 2025 systematic review and meta-analysis of seven randomised controlled trials in postmenopausal women. Pooled results favoured creatine for lean mass, with a mean difference of about +0.37 kg versus placebo, and for leg-press strength, at roughly +7.5 kg.

Let's be honest about what those numbers mean. A third of a kilogram of lean tissue is not a transformation. Nobody looks different. But in a life stage where the default trajectory is losing muscle every year, a small gain in the opposite direction is meaningful - and the strength number is more practically relevant. Seven and a half kilos more on a leg press translates to real-world capability: getting off the floor, carrying things upstairs, catching yourself when you stumble.

The critical qualifier: creatine did not work on its own. In nearly every trial, both groups were resistance training. Creatine was the small addition on top of the thing that actually caused the change. If you take creatine and don't lift, you'll mostly gain a little water weight in the muscle cells and not much else.

There's also emerging work on mechanism. A 2025 study found creatine monohydrate increased skeletal muscle microvascular blood flow and promoted lipid mobilisation in postmenopausal women, which suggests effects beyond simple energy buffering - though this is early and needs replication.

If you're not already lifting, that's the higher-leverage change. Our guide to [resistance training for menopause](/blog/resistance-training-for-menopause-why-lifting-matters) covers where to start, including if you've never touched a weight.

Probably not in the way the internet suggests - and this is where the evidence gets misrepresented most often.

The largest test was a 2-year randomised controlled trial in 237 postmenopausal women (mean age 59), all doing a supervised resistance training and walking programme, randomised to creatine or placebo. The headline result: no difference in bone mineral density at the femoral neck, total hip, or lumbar spine.

That's a well-powered, long-duration, negative result for BMD. It deserves to be stated plainly, because a lot of supplement marketing implies the opposite.

But the same trial found something more interesting. Creatine improved certain bone geometry properties at the proximal femur - measures like section modulus and buckling ratio, which describe how bone is distributed and how well a bone resists bending and snapping. Bone strength isn't only about density; it's also about shape and architecture. A slightly wider bone with the same density is a stronger bone. An earlier 12-month trial by the same research group had pointed in a similar direction, showing preserved femoral neck density and increased subperiosteal width.

So the fair reading: creatine is not an osteoporosis treatment and should never substitute for one. If you have osteopenia or osteoporosis, the evidence-based interventions are resistance and impact training, adequate calcium and vitamin D, and - where appropriate - hormone therapy or a bone-specific medication. Creatine may add a small structural benefit alongside training. That's the honest ceiling.

For what actually moves bone density, see our [osteoporosis prevention guide](/blog/osteoporosis-prevention-in-menopause-what-actually-works) and the numbers on [calcium and vitamin D in menopause](/blog/calcium-and-vitamin-d-for-menopause-how-much-you-need).

There's a plausible mechanism and some early data, but nothing menopause-specific yet.

Your brain uses creatine too. Neurons are energy-hungry, and brain phosphocreatine buffers ATP the same way it does in muscle. Brain creatine stores drop under stress states - notably sleep deprivation - which is exactly the state a lot of women in perimenopause are living in.

What's been shown: a 2018 systematic review and meta-analysis (Avgerinos et al., *Experimental Gerontology*) found creatine supplementation improved short-term memory and some measures of intelligence and reasoning in healthy adults, with effects most visible in older adults and vegetarians - groups with lower baseline stores. Separate studies have found creatine partially offsets the cognitive decline caused by sleep deprivation.

What has not been shown: that creatine improves menopausal brain fog specifically. No trial has tested it in perimenopausal or postmenopausal women with cognitive complaints. The extrapolation is reasonable, but it's still an extrapolation, and anyone selling creatine as a brain-fog cure is ahead of the evidence.

Mood is similarly preliminary. Small trials have explored creatine as an add-on to antidepressants, with some positive signals, particularly in women. It's an active research area rather than a settled finding.

One practical note: creatine is not a stimulant and does not interfere with sleep. You can take it at any time of day. If you're dealing with cognitive changes in midlife, the interventions with actual evidence behind them - sleep, exercise, and where appropriate hormone therapy - are covered in our piece on [menopause brain fog](/blog/menopause-brain-fog-why-it-happens-and-what-helps).

3 to 5 grams of creatine monohydrate, once daily, every day. That's the whole protocol.

Form: creatine monohydrate. It is the form used in essentially every trial cited here, it's the cheapest, and no alternative form - hydrochloride, ethyl ester, buffered, liquid - has been shown to outperform it. Products marketed as more "absorbable" are charging more for a solved problem. Look for micronised monohydrate, which simply dissolves better. If you want a quality marker, Creapure is a widely used certified source, and third-party testing marks like NSF Certified for Sport or Informed Choice tell you what's in the tub matches the label.

Loading phase: unnecessary. The classic protocol of 20 g a day for five days saturates muscle faster, but 3-5 g daily reaches the same saturation in roughly three to four weeks, with far less GI upset. In midlife there's no reason to rush it.

Timing: it doesn't matter much. Creatine works by saturating a store over weeks, not by acting acutely. Take it whenever you'll remember - many people attach it to coffee or a morning smoothie. Taking it with carbohydrate or protein may slightly improve uptake, which is a reasonable tiebreaker but not a rule.

How to take it: stir into water, coffee, tea or a smoothie. It's largely tasteless. It doesn't need to be cold, and heat doesn't destroy it over normal timescales.

Water: creatine pulls a small amount of water into muscle cells. Drink normally - you don't need to force extra fluid, but chronic under-hydration isn't helpful either.

Consistency beats dose. Missing days matters more than the exact gram count, because the benefit comes from a saturated store maintained over months.

Creatine is one of the most studied supplements in existence, and the safety record is reassuring for healthy adults.

Kidneys. This is the most persistent myth. It comes from a real observation: creatine supplementation raises blood creatinine, a waste product used to estimate kidney function. Higher creatinine looks like worse kidney function on a lab report - but in this case it reflects more creatine in the system, not damage. The International Society of Sports Nutrition position stand (Kreider et al., *JISSN*, 2017) concluded there is no evidence of kidney harm from long-term creatine use in healthy individuals, with trials running up to five years. However: if you have existing kidney disease, discuss it with your doctor first. And mention that you take creatine before any blood test, so an elevated creatinine isn't misread.

Bloating and water weight. Creatine draws water *into* muscle cells, not under the skin. You may see the scale rise 0.5-1 kg in the first week or two. That's intracellular water, and it's arguably a good thing - hydrated muscle cells are metabolically favourable. Bloating and GI upset are mainly a loading-phase problem. Skip loading and take 3-5 g with food and it's uncommon.

Hair loss. This fear traces to a single 2009 study of 20 college rugby players that found a rise in DHT, a hormone linked to pattern hair loss. That study never measured hair. It has not been replicated, and no trial has ever shown creatine causing hair loss. Given how many women in midlife are already dealing with thinning hair, it's worth saying clearly: the evidence for this is essentially one small study that didn't look at hair.

Who should check first: anyone with kidney or liver disease, anyone pregnant or breastfeeding, and anyone on multiple medications - a quick word with your pharmacist covers it.